title: The influence of photodynamic therapy on the ultrastructure of the normal rat bladder.
abstract: Reduced bladder capacity is a major side effect for patients receiving photodynamic therapy (PDT) for bladder cancer. A rat bladder model has been developed to address both the vascular and tissue effects of the photodynamic treatment of the urinary bladder. Bladders were exteriorized and positioned in a plexiglass tissue bath. Effects on microvasculature were assessed during PDT of the bladder by recording luminal diameter changes in arterioles and venules. Animals receiving Photofrin II (10 mg kg-1) 30 min prior to PDT scored a statistically significant reduction in the diameter of the red blood cell column in the vessels, whereas administration of Photofrin II 48 h prior to PDT was ineffective. Morphological changes included significant endothelial and vascular myocyte damage in the 30 min PDT group alone. Among the other tissue components, the mucosal lining was minimally affected and the response of the muscularis was highly variable. Smooth muscle cell changes ranged from mild contraction to frank necrosis with many of the affected cells located near the altered vascular beds. These data suggest that the clinical symptoms of reduced bladder capacity can be accounted for by vascular damage and myocyte sensitivity. Further refinements in the Photofrin II and light doses used in therapy may reduce bladder complications and allow for better management of bladder cancer.
authors.affiliation: Department of Anatomical Sciences and Neurobiology, University of Louisville, KY 40292.
authors.forename: M T
authors.initials: MT
authors.lastname: Tseng
authors.forename: D A
authors.initials: DA
authors.lastname: Schuschke
authors.forename: M W
authors.initials: MW
authors.lastname: Reed
authors.forename: J I
authors.initials: JI
authors.lastname: Harty
authors.forename: T J
authors.initials: TJ
authors.lastname: Wieman
authors.forename: V H
authors.initials: VH
authors.lastname: Fingar
mesh_terms: D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000648:ultrastructure; D002196:Capillaries / Q000187:drug effects / Q000648:ultrastructure; D017323:Dihematoporphyrin Ether; D005260:Female; D006415:Hematoporphyrins / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000648:ultrastructure; D010778:Photochemotherapy; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012039:Regional Blood Flow / Q000187:drug effects; D001743:Urinary Bladder / Q000098:blood supply / Q000187:drug effects / Q000648:ultrastructure*; D014699:Venules / Q000187:drug effects / Q000648:ultrastructure
chemical_list: D006415:Hematoporphyrins; D011838:Radiation-Sensitizing Agents; D017323:Dihematoporphyrin Ether